Skinvisible Pharmaceuticals, Inc.
Records under this name other than the patents Skinvisible Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 6 of 6 · Back to Skinvisible Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,318,818 | Topical composition, topical composition precursor, and methods for manufacturing and using Term ended Term ended Jul 10, 2025 · USPTO record | Term ended | Term ended Jul 10, 2025 | USPTO record |
| US 8,299,122 | Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition Lapsed on the fee record Ended Oct 30, 2024 · USPTO record | Lapsed on the fee record | Ended Oct 30, 2024 | USPTO record |
| US 7,674,471 | Topical composition, topical composition precursor, and methods for manufacturing and using Term ended Term ended Feb 27, 2024 · USPTO record | Term ended | Term ended Feb 27, 2024 | USPTO record |
| US 8,481,058 | Topical composition, topical composition precursor, and methods for manufacturing and using Term ended Term ended Sep 19, 2022 · USPTO record | Term ended | Term ended Sep 19, 2022 | USPTO record |
| US 6,756,059 | Topical composition, topical composition precursor, and methods for manufacturing and using Term ended Term ended Aug 20, 2021 · USPTO record | Term ended | Term ended Aug 20, 2021 | USPTO record |
| US 6,582,683 | Dermal barrier composition Term ended Term ended Jan 4, 2020 · USPTO record | Term ended | Term ended Jan 4, 2020 | USPTO record |